Ryman Healthcare - Source Brief - FY26 Annual Report
Ryman Healthcare Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
Ryman’s New Zealand and Victorian operations; FY26 year ended 31 March 2026
Medium confidence
verified
Primary-source research review
Evidence boundary: Authored synthesis of provider reporting, not another issuer original. Reconciled to all 130 physical pages of doc-0206 on 10 October 2026; preserved original June brief text/hash in dedicated source audit. Primary link corrected from separate bond proposal 473748 to annual-report release 473909. Finance-cost and impairment gross/net comparisons, per-bed half-year denominator, conditional dividends, care-centre closures and June policy chronology corrected. Original year-only brief publication precision, filename/category/June access retained; 5 June is the underlying report date. Section 9’s historic 8 June news/analyst additions remain expressly unverified historical assertions. Provider operational and financial boundaries in doc-0206 apply; no independent clinical validation, live vacancies, current individual contracts or investment advice.
Short Answer
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.
Why it matters
Trace dated operator scale, care occupancy and capital strategy against financial accounts; test mature-site, cross-country, non-GAAP and survey denominators before comparison, and seek current site-level evidence for service access.
Key Points
- •FY26 covers 1 April 2025–31 March 2026. NZX released the annual report on 5 June 2026 at 08:30 NZST; financial statements were authorised on 25 May. The preserved PDF has 130 physical pages, not 206 (inside cover; printed p. 45; NZX announcement 473909).
- •FY26 overview reports 47 villages including two under construction: NZ 38/Australia 9; 9,959 retirement units: NZ 8,379/Australia 1,580; and 4,686 aged-care beds: NZ 3,927/Australia 759. These are company portfolio counts, not current certified/staffed capacity or vacancies (printed p. 3).
- •Overview reports 15,547 residents (NZ 13,069/Australia 2,478) and 7,778 team members (NZ 6,072/Australia 1,706). Team members span the organisation; no care-worker-only/FTE or staffing-ratio denominator is established by this headline (printed p. 3).
- •FY26 care occupancy averaged 96.0% in mature care facilities across NZ and Australia, versus 96.3% FY25. The headline does not state the mature-facility/bed denominator, weighting or maturity cutoff; it is not all-company or national occupancy and cannot establish current vacancies (printed pp. 6–7).
- •Adjusted operating revenue was NZ$849.064m and Operating EBITDAF NZ$88.299m versus NZ$771.131m/NZ$45.524m FY25. These company non-GAAP measures differ from statutory total revenue NZ$855.590m; reconciliation appears in note 2 (printed pp. 42,49,53–54).
- •Statutory FY26 net loss after tax was NZ$171.345m versus restated FY25 loss NZ$513.747m. FY26 included a NZ$104.304m negative investment-property fair-value movement; PBTF loss NZ$73.309m is separately defined as non-GAAP (printed pp. 42,49,54).
Full Summary & Notes
Authored historical brief of Ryman’s FY26 annual report, reconciled on 10 October 2026 against all 130 original pages. Separates statutory losses and restated comparisons from adjusted EBITDAF and free cash flow; corrects finance costs that fell 42.4%, not halved, and gross impairment charges offset by reversals. Mature NZ/AU occupancy, organisation-wide headcounts and survey scores retain their evidence limits. June news additions remain historical capture, not current verified events.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
42-page FY2026 financial annual report with a short portfolio and leadership overview, audited statements, valuation and resident-loan notes, planned development and limited resident-feedback reporting; separate from the two-page results release.
Four-page May 2026 issuer release on reported care occupancy, adjusted earnings, planned Karori acquisition, new-build care projects and home-support expansion; forecast capacity and promotional service claims require separate verification.
Historical FY25 Radius company report: portfolio activity, diversification, development plans, governance and audited group accounts; not a national capacity, staffing or clinical-quality assessment.